Circassia Pharmaceuticals(GB:NIOX)
GBX 63.60-0.80 (-1.24%)
GB:NIOX
Circassia Pharmaceuticals Revenue
GBX 63.60
At close:-0.80 (-1.24%)
Want to see GB:NIOX full AI Analyst Report?
Circassia Pharmaceuticals (NIOX) Revenue
14 Followers
Circassia Pharmaceuticals Revenue
Circassia Pharmaceuticals had a revenue of 24.00M in the quarter ending Jun 30, 2026, with 2.13%. This bring the company's revenue in the last twelve months to 47.50M, Decreased 2.46%. In the fiscal year ending Dec 31, 2025, Circassia Pharmaceuticals had annual revenue of 48.70M with 16.51% growth.
- Revenue (ttm)
- 47.50M
- Revenue Growth
- 3.26%
- P/S Ratio
- 5.36
- Revenue/Employee
- GBP 502,062
- Employees
- 97
- Market Cap
- GBP 261.00M
Revenue Chart
Circassia Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48.70M | 6.90M | 16.51% |
| Dec 31, 2024 | 41.80M | 5.00M | 13.59% |
| Dec 31, 2023 | 36.80M | 5.50M | 17.57% |
| Dec 31, 2022 | 31.30M | 3.40M | 12.19% |
| Dec 31, 2021 | 27.90M | 4.00M | 16.74% |
| Dec 31, 2020 | 23.90M | -10.70M | -30.92% |
| Dec 31, 2019 | 34.60M | -13.70M | -28.36% |
| Dec 31, 2018 | 48.30M | 2.00M | 4.32% |
| Dec 31, 2017 | 46.30M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.